Vitrolife AB (CHIX:VITRS) Accounts Payable: kr184 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:VITRS Vitrolife AB CHIX:VITRS
77 GF Score
Price kr105.75
GF Value kr178.62
! 6 Warning Signs
View Full Analysis

What is Vitrolife AB Accounts Payable?

Vitrolife AB CHIX:VITRS 77 Accounts Payable is kr184 Mil as of Jun. 2026. GuruFocus rates CHIX:VITRS with a GF Score™ of 77/100 and a GF Value™ of kr178.62. The stock has 6 warning signs investors should review.

Vitrolife AB's Accounts Payable for the quarter that ended in Jun. 2026 was kr184 Mil.

Vitrolife AB's quarterly Accounts Payable declined from Dec. 2025 (kr208 Mil) to Mar. 2026 (kr173 Mil) but then increased from Mar. 2026 (kr173 Mil) to Jun. 2026 (kr184 Mil).

Vitrolife AB's annual Accounts Payable increased from Dec. 2023 (kr171 Mil) to Dec. 2024 (kr203 Mil) and increased from Dec. 2024 (kr203 Mil) to Dec. 2025 (kr208 Mil).

Vitrolife AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Vitrolife AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB Accounts Payable Chart

Vitrolife AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.00 181.00 171.00 203.00 208.00

Vitrolife AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.00 167.00 208.00 173.00 184.00
CHIX:VITRS
77GF Score
Vitrolife AB CHIX:VITRS
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vitrolife AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of kr184 Mil mean?
Vitrolife AB (CHIX:VITRS) has a Accounts Payable of kr184 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Vitrolife AB and its competitors.
Is Vitrolife AB's Accounts Payable too high?
Vitrolife AB's current Accounts Payable is kr184 Mil. Overall, Vitrolife AB has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Accounts Payable compare to ABT and SYK?
Vitrolife AB's Accounts Payable of kr184 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Vitrolife AB and its competitors. Vitrolife AB's current Accounts Payable is kr184 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Vitrolife AB (CHIX:VITRS) has a current Accounts Payable of kr184 Mil. The stock's GF Value™ is kr178.62, compared to a current price of kr105.75 — trading 40.8% below its estimated fair value. The current Accounts Payable is kr184 Mil. Vitrolife AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Vitrolife AB (CHIX:VITRS), the current Accounts Payable is kr184 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vitrolife AB (CHIX:VITRS) Overvalued in 2026?

Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued. The current stock price of kr105.75 is trading 40.8% below its estimated GF Value™ of kr178.62.

Key valuation signals for CHIX:VITRS:

  • Accounts Payable: kr184 Mil
  • GF Value™: kr178.62 vs. price of kr105.75 (40.8% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the CHIX:VITRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vitrolife AB Business Description

Address Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
77GF Score

Get the complete analysis for CHIX:VITRS

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr105.75
Price
kr178.62
GF Value